Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
Clinical trial NCT02503423 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02503423
- Sponsor
- Taiho Oncology, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-14
- Primary completion
- 2022-10-01
- Enrollment
- 253
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.